✦ LIBER ✦

Comparison of Usefulness of Simvastatin 20 mg Versus 80 mg in Preventing Contrast-Induced Nephropathy in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

✍ Scribed by Jia Xinwei; Fu Xianghua; Zhang Jing; Gu Xinshun; Xue Ling; Fan Weize; Hao Guozhen; Jiang Yunfa; Wu Weili; Li Shiqiang

Book ID: 113445935
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 326 KB
Volume: 104
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2009.04.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV46 ECONOMIC EVALUATION OF 80 MG ATORV

PCV46 ECONOMIC EVALUATION OF 80 MG ATORVASTATIN COMPARED TO 20-40 MG SIMVASTATIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES

✍ P Lindgren; AG Olsson; T Pedersen; B Jónsson 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Prevention of contrast-induced nephropat

Prevention of contrast-induced nephropathy with prostaglandin E1in high-risk patients undergoing percutaneous coronary intervention

✍ Li, Wen-Hua; Li, Dong-Ye; Qian, Wen-Hao; Liu, Jia-Li; Xu, Tong-Da; Zhu, Hong; He 📂 Article 📅 2014 🏛 Springer Netherlands 🌐 English ⚖ 322 KB

Comparison of Risks and Clinical Predict

Comparison of Risks and Clinical Predictors of Contrast-Induced Nephropathy in Patients Undergoing Emergency versus Nonemergency Percutaneous Coronary Interventions

✍ ERIC CHONG; KIAN K. POH; SHEN LIANG; CHAO Y. SOON; HUAY-CHEEM TAN 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB

Contemporary Use and Effectiveness of N-

Contemporary Use and Effectiveness of N-Acetylcysteine in Preventing Contrast-Induced Nephropathy Among Patients Undergoing Percutaneous Coronary Intervention

✍ Hitinder S. Gurm; Dean E. Smith; Otavio Berwanger; David Share; Theodore Schreib 📂 Article 📅 2012 🏛 American College of Cardiology 🌐 English ⚖ 780 KB

Usefulness of Statin Pretreatment to Pre

Usefulness of Statin Pretreatment to Prevent Contrast-Induced Nephropathy and to Improve Long-Term Outcome in Patients Undergoing Percutaneous Coronary Intervention

✍ Giuseppe Patti; Annunziata Nusca; Massimo Chello; Vincenzo Pasceri; Andrea D’Amb 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 312 KB

Short-Term, High-Dose Atorvastatin Pretr

Short-Term, High-Dose Atorvastatin Pretreatment to Prevent Contrast-Induced Nephropathy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the ARMYDA-CIN [Atorvastatin for Reduction of MYocardial Damage during Angioplasty–Contrast-Induced Nephropathy] Trial

✍ Giuseppe Patti; Elisabetta Ricottini; Annunziata Nusca; Giuseppe Colonna; Vincen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 811 KB